Literature DB >> 8731515

Reduced beta-adrenergic receptor-coupled Gs protein function and Gs alpha immunoreactivity in mononuclear leukocytes of patients with depression.

S Avissar1, L Barki-Harrington, Y Nechamkin, G Roitman, G Schreiber.   

Abstract

beta-Adrenergic receptor-coupled Gs protein function was measured in 26 depressed patients through cholera toxin-sensitive, isoproterenol-induced increases in 3H-Gpp(NH)p binding capacity to mononuclear leukocytes (MNL). Highly significant reductions in receptor-coupled Gs protein function were observed in the depressed patients: 2.0 +/- 1.3% increases in guanine nucleotide-binding capacity, in comparison with the control group values of 28.3 +/- 6.9%. Similar reductions in Gs protein function were detected in both uni- and bipolar depressed patients. A significant negative correlation was found between receptor-coupled Gs protein measures and the severity of depression. Adding semiquantitative measures of MNL Gs alpha through immunoblot analysis by use of polyclonal antibodies against Gs alpha subunit, it was found that Gs alpha relative immunoreactivity was reduced from 100 +/- 2.0% in the control group of subjects to 75.9 +/- 2.3% in the depressed patients. We have previously described hyperfunctional Gs proteins in leukocytes of patients with mania. The present findings of reduced function of Gs in depressed patients suggests receptor-coupled Gs protein activity as a biochemical parameter indicatory of the affective state. Reduced receptor-coupled Gs protein function may reflect reduced levels of the beta-adrenergic receptor previously shown in leukocytes of depressed patients; however, our complementary immunoblot studies suggest a direct, postreceptor, quantitative, and functional reduction in Gs protein in MNL of depressed patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731515     DOI: 10.1016/0006-3223(95)00248-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.

Authors:  Dena Firouzabadi; Negar Firouzabadi; Kiana Kalani; Kamyar Zomorrodian; Elham Shirazi Tehrani
Journal:  Eur J Clin Pharmacol       Date:  2018-10-15       Impact factor: 2.953

2.  Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.

Authors:  S Avissar; G Roitman; G Schreiber
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 3.  The role of G proteins in the psychobiology and treatment of affective disorders and their integration with the neurotransmitter hypothesis.

Authors:  S Avissar
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

4.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 5.  Glycosides, depression and suicidal behaviour: the role of glycoside-linked proteins.

Authors:  Gianluca Serafini; Maurizio Pompili; Marco Innamorati; Gloria Giordano; Roberto Tatarelli; David Lester; Paolo Girardi; Yogesh Dwivedi
Journal:  Molecules       Date:  2011-03-23       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.